Pharma

Please join us for our quarterly Life Sciences Investor Forum. This day-long event will feature companies from the life sciences industry. More information will be available closer to the event date.

BioTrinity is OBN’s flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. Including a mix of early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers.

Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.

Empowering innovation, accelerating investment and facilitating knowledge and networking to shape the future of healthcare Where innovators, investors and senior life science dealmakers in the LSX community connect, learn and partner

This prestigious conference is an exclusive global partnering forum that brings together nearly 600 senior executives and CEOs, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies from over 20 countries. This conference features panel discussions and keynote presentations, one-on-one partnering meetings, small company presentations, presentations from leading research institutions, and endless networking opportunities

BioCapital Europe is Europe’s premier life sciences investment conference, offering VCs and Institutional Investors unique and timely access to around 40 exciting biotech, medtech and diagnostics companies from the Benelux and Europe.

[From 2021] Conditions permitting, we plan to host the conference both in-person in London and virtually. This year marks the 12th anniversary of the largest healthcare-dedicated conference in Europe. In 2020, we hosted over 550 participating companies, 3,000 attendees, and 6,500 business-to-business and investor meetings. Our conference will again feature leading public and private companies from the pharmaceuticals, biotechnology, medical technology, and healthcare services sectors from the Americas, Europe, Middle East, Africa, Asia, and Australia.

Interest in the field of health economics and outcomes research (HEOR) has grown exponentially as governments and other payers grapple with how to provide the best possible health outcomes at affordable costs. Renowned as the global Society that convenes all healthcare stakeholders in HEOR, ISPOR is leading the field at a time when solid approaches to decision making are more important than ever.

The European Medicines Agency (EMA) have issued a network strategy to 2025 with the mission: Protecting Public Health at a Time of Rapid Change. The strategic focus areas are availability and accessibility of medicines, data analytics-digital tools and digital transformation, innovation, anti-microbial resistance, other emerging health threats, supply chain challenges, sustainability of the network and operational excellence. This sets the framework for the 2022 ISPE Europe Annual Conference in Madrid in April. High level speakers from the European Commission, the European Federation of Pharmaceutical Industries’ Associations (EFPIA) as well as European National Competent Authorities engaged in sustainability will give input to ISPEs well known traditional Executive Forum. Special focus will feature industry speakers on learnings from the COVID-19 crisis and the management of vaccine production and logistics.

Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs – join the discussion in Dublin, or attend from home via a digital pass. Plus take advantage of two bonus days of digital 1×1 meetings. Additional details to be released shortly, check back for updates.